Lucinda Crabtree joins Oxford Biomedica today as Chief Financial Officer

Lucinda Crabtree joins Oxford Biomedica today as Chief Financial Officer

Oxford, UK – September 2, 2024: Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica”, “OXB” or “the Company”), a quality and innovation-focused CDMO for cell and gene therapy, announces that Lucinda (Lucy) Crabtree Ph.D. has today joined Oxford Biomedica as Chief Financial Officer (CFO) and a Board Member. Lucinda’s appointment was previously announced on 17 July 2024.